Track Record
Transactions
The team has completed over 300 transactions and engagements for its clients — valued at over $35 billion — as Bookrunner, Co-Manager, Lead Placement Agent, Co-Placement Agent or Advisor.
Featured Transactions
- April 2025
Alcyone TherapeuticsBrookline served as Exclusive Placement Agent for the Series F Convertible Preferred stock offering. - September 2025
Sale to BiogenBiogen acquired Alcyone Therapeutics in 2025. Brookline served as Alcyone's financial advisor. - July 2026
Neela TherapeuticsNeela Therapeutics was spun out of the acquisition and Brookline served as the Exclusive Placement Agent for a Convertible Note in 2026.
Selected Client Transactions
Transaction results

Western Acquisition Ventures Corp.
$115,000,000
IPOCo-Manager

Circulogene
$15,100,000
Convertible NoteSole Placement Agent

PIMCO Access Income Fund
$866,000,000
IPOCo-Manager

RH
$936,435,859
Convertible & Derivative Unwind Advisory100% Unwind of Tax-Integrated Warrant and Bond Hedge & Concurrent 2023 & 2024 Convertible Debt Repurchase

Inception Growth Acquisition Limited
$103,500,000
IPOJoint Bookrunner

Nuveen Variable Rate Preferred & Income Fund
$550,000,000
IPOCo-Manager

IceCure Medical
$15,000,000
Follow-OnCo-Manager

Alpha Star Acquisition Corporation
$115,000,000
IPOCo-Manager

Ault Disruptive Technologies Corporation
$115,000,000
IPOCo-Manager

Larkspur Health Acquisition Corp.
$77,700,000
IPOCo-Manager

Guggenheim Active Allocation Fund
$655,000,000
IPOCo-Manager

New York Life Investments Mainstay CBRE Global Infrastructure Megatrends Fund
$1,000,000,000
IPOCo-Manager

Maxona Pharmaceuticals
$10,000,000
Series A Convertible Preferred StockSole Placement Agent

Creatd
$3,825,000
Registered DirectFinancial Advisor

CohBar
$15,000,000
Follow-OnCo-Manager

Mount Rainier Acquisition Corp.
$172,500,000
IPOCo-Manager

Industrial Human Capital
$115,000,000
IPOCo-Manager

HHG Capital Corporation
$57,500,000
IPOJoint Bookrunner

BlackRock ESG Capital Allocation Trust
$2,000,000
IPOCo-Manager

Lisata Therapeutics
Completed EngagegmentCapital Markets Advisor

Nova Vision Acquisition Corporation
$57,500,000
IPOJoint Bookrunner

Dermata Therapeutics
$18,000,000
IPOCo-Manager

Jupiter Acquisition Corp.
$157,600,000
IPOJoint Bookrunner

Journey Medical Corporation
$18,850,000
Series A Convertible Preferred StockSub Placement Agent